Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages

  Jin, Ran ^a,b   Le, Ngoc Anh ^a,b   Liu, Shuling ^a   Epperson, Monica Farkas ^a   Ziegler, Thomas R ^a   Welsh, Jean A ^a,f   Jones, Dean P ^a   McClain, Craig J ^c,d,e   Vos, Miriam B ^a,f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; NITROGEN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FEMALE; FOOD COMPOSITION; FRUCTOSE BEVERAGE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MACRONUTRIENT; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL;

ADOLESCENT; BEVERAGES; BLOOD GLUCOSE; CHILD; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DISEASE SUSCEPTIBILITY; DOUBLE-BLIND METHOD; FATTY LIVER; FEMALE; FRUCTOSE; HUMANS; INSULIN; LIPIDS; MALE; METABOLIC DISEASES; RISK FACTORS;

ANIMALIA;

EID: 84863580211     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1370     Document Type: Article

References (55)

1. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C 2006 Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388-1393 (Pubitemid 46393782)
2. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P 2009 The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 58:1538-1544
3. Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R 2010 Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51:595-602
4. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P 2005 The natural history of nonalcoholic fatty liver disease: a population based cohort study. Gastroenterology 129:113-121 (Pubitemid 41002048)
5. Ramilli S, Pretolani S, Muscari A, Pacelli B, Arienti V 2009 Carotid lesions in outpatients with nonalcoholic fatty liver disease. World J Gastroenterol 15:4770-4774
6. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S 2008 Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 118:277-283
7. Quirós-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF 2007 Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. J Pediatr Gastroenterol Nutr 44:228-236 (Pubitemid 46175078)
8. Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, Anania C, Ferrara E, Dvisic G, Chiesa C 2008 Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 63:423-427 (Pubitemid 351450591)
9. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V 2008 Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 32:381-387 (Pubitemid 351271778)
10. Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, Bedogni G 2007 Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 61:877-883 (Pubitemid 47040311)
11. Sacks FM 2002 The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol 90:139-143 (Pubitemid 34775122)
12. Magnussen CG, Niinikoski H, Juonala M, Kivimaki M, Ronnemaa T, Viikari JS, Simell O, Raitakari OT 30 August 2011 When and how to start prevention of atherosclerosis? Lessons from the Cardiovascular Risk in the Young Finns Study and the Special Turku Coronary Risk Factor Intervention Project. Pediatr Nephrol doi: 10.1007/s00467-011-1990-y
13. Musso G, Gambino R, Cassader M, Pagano G 2011 Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43:617-649
14. Talayero BG, Sacks FM 2011 The role of triglycerides in atherosclerosis. Curr Cardiol Rep 13:544-552
15. Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM 2008 Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 10:160
16. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I 2008 Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138:1452-1455
17. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF 2008 Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993-999
18. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N 2009 Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 51:918-924
19. Parks EJ, Skokan LE, Timlin MT, Dingfelder CS 2008 Dietary sugars stimulate fatty acid synthesis in adults. J Nutr 138:1039-1046 (Pubitemid 351769126)
20. Chong MF, Fielding BA, Frayn KN 2007 Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr 85:1511-1520 (Pubitemid 46890417)
21. Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC 2008 Antibiotics protect against fructoseinduced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48:983-992
22. Jürgens H, Haass W, Castañeda TR, Schürmann A, Koebnick C, Dombrowski F, Otto B, Nawrocki AR, Scherer PE, Spranger J, Ristow M, Joost HG, Havel PJ, Tschöp MH 2005 Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 13:1146-1156
23. Havel PJ 2005 Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63:133-157
24. Kunde SS, Roede JR, Vos MB, Orr ML, Go YM, Park Y, Ziegler TR, Jones DP 2011 Hepatic oxidative stress in fructose induced fatty liver is not caused by sulfur amino acid insufficiency. Nutrients 3:987-1002
25. Bantle JP, Raatz SK, Thomas W, Georgopoulos A 2000 Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr 72:1128-1134
26. Hallfrisch J, Reiser S, Prather ES 1983 Blood lipid distribution of hyperinsulinemic men consuming three levels of fructose. Am J Clin Nutr 37:740-748 (Pubitemid 13094856)
27. Teff KL, Elliott SS, Tschöp M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ 2004 Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 89:2963-2972 (Pubitemid 38766393)
28. Stanhope KL, Griffen SC, Bremer AA, Vink RG, Schaefer EJ, Nakajima K, Schwarz JM, Beysen C, Berglund L, Keim NL, Havel PJ 2011 Metabolic responses to prolonged consumption of glucoseand fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am J Clin Nutr 94:112-119
29. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ 2009 Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119:1322-1334
30. Sharma P, Martin DR, Pineda N, Xu Q, Vos M, Anania F, Hu X 2009 Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction. J Magn Reson Imaging 29:629-635
31. Pineda N, Sharma P, Xu Q, Hu X, Vos M, Martin DR 2009 Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy-a rapid and accurate technique. Radiology 252:568-576
32. Stanhope KL, Bremer AA, Medici V, Nakajima K, Ito Y, Nakano T, Chen G, Fong TH, Lee V, Menorca RI, Keim NL, Havel PJ 2011 Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab 96:E1596-E1605
33. Ahrens Jr EH, Hirsch J, Oette K, Farquhar JW, Stein Y 1961 Carbohydrate-induced and fat-induced lipemia. Trans Assoc Am Physicians 74:134-146
34. Ginsberg HN, Le NA, Melish J, Steinberg D, Brown WV 1981 Effect of a high carbohydrate diet on apoprotein-B catabolism in man. Metabolism 30:347-353 (Pubitemid 11101147)
35. Melish J, Le NA, Ginsberg H, Steinberg D, Brown WV 1980 Dissociation of apoprotein B and triglyceride production in very-lowdensity lipoproteins. Am J Physiol 239:E354-E362 (Pubitemid 11243370)
36. Couchepin C, Lê KA, Bortolotti M, da Encarnaçao JA, Oboni JB, Tran C, Schneiter P, Tappy L 2008 Markedly blunted metabolic effects of fructose in healthy young female subjects compared with male subjects. Diabetes Care 31:1254-1256
37. Lê KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C, Ravussin E, Tappy L 2006 A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 84:1374-1379 (Pubitemid 44912820)
38. Stanhope KL, Havel PJ 2008 Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 19:16-24
39. Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB 2010 Caloric sweetener consumption and dyslipidemia among US adults. JAMA 303:1490-1497
40. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ 2005 Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351 (Pubitemid 40629054)
41. Calabresi L, Franceschini G, Sirtori M, Gianfranceschi G, Werba P, Sirtori CR 1990 Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease. Atherosclerosis 84:41-48 (Pubitemid 20267453)
42. Rashid S, Watanabe T, Sakaue T, Lewis GF 2003 Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem 36:421-429 (Pubitemid 37083556)
43. Ginsberg HN 1996 Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 45(Suppl 3):S27-S30
44. Lamarche B, Uffelman KD, Carpentier A, Cohn JS, Steiner G, Barrett PH, Lewis GF 1999 Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 103:1191-1199 (Pubitemid 29207253)
45. Welsh JA, Sharma A, Cunningham SA, Vos MB 2011 Consumption of added sugars and indicators of cardiovascular disease risk among US adolescents. Circulation 123:249-257
46. Balletshofer BM, Rittig K, Volk A, Maerker E, Jacob S, Rett K, Häring H 2001 Impaired non-esterified fatty acid suppression is associated with endothelial dysfunction in insulin resistant subjects. Horm Metab Res 33:428-431 (Pubitemid 32721526)
47. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK 1999 Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest 104:1087-1096 (Pubitemid 29536319)
48. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM 2007 Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45:1366-1374 (Pubitemid 46918320)
49. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ 2004 Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway. Hepatology 40:185-194 (Pubitemid 38868937)
50. Nehra V, Angulo P, Buchman AL, Lindor KD2001 Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 46:2347-2352 (Pubitemid 33042332)
51. Pollock NK, Bundy V, Kanto W, Davis CL, Bernard PJ, Zhu H, Gutin B, Dong Y 2012 Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents. J Nutr 142:251-257
52. Vos MB, Weber MB, Welsh J, Khatoon F, Jones DP, Whitington PF, McClain CJ 2009 Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: a pilot study. Arch Pediatr Adolesc Med 163:674-675
53. Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, Rosenthal P, Schwimmer JB, Tonascia J, Unalp A, Lavine JE 2012 Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 54:90-96
54. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM 2010 Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51:1961-1971
55. Welsh JA, Sharma AJ, Grellinger L, Vos MB 2011 Consumption of added sugars is decreasing in the United States. Am J Clin Nutr 94:726-734